Volume 138, Issue 7, Pages (June 2010)

Slides:



Advertisements
Similar presentations
Covert Hepatic Encephalopathy Diagnosis With The New Stroop App (EncephalApp) Using Age-Based Cut-off Values Jasmohan S. Bajaj 1, Douglas M. Heuman 1,
Advertisements

Volume 140, Issue 2, Pages e1 (February 2011)
Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy  Jasmohan S. Bajaj, Douglas M. Heuman, Richard.
Christoph Lübbert, Babett Holler  Gastroenterology 
Volume 145, Issue 6, Pages e3 (December 2013)
Volume 144, Issue 5, Pages (May 2013)
Covering the Cover Gastroenterology
Jesús Rivera–Nieves, María T. Abreu  Gastroenterology 
Covering the Cover Gastroenterology
Outcomes Among Living Liver Donors
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Gastroenterology 2011–2016: Looking Back and Forward
Covert Hepatic Encephalopathy: Not as Minimal as You Might Think
Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy  Jasmohan S. Bajaj, Douglas M. Heuman, Richard.
Clinical Challenges and Images in GI
Unusual Case of an Upset Stomach
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Volume 154, Issue 4, Pages (March 2018)
Abdominal Pain in a Patient 13 Years After Roux-en-Y Gastric Bypass
Volume 152, Issue 5, Pages e1 (April 2017)
Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy  Kevin D. Mullen, Arun J. Sanyal, Nathan.
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Colon Cancer: An Update and Future Directions
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
The 75th Diamond Anniversary of Gastroenterology: 1943–2018
Rafael Esteban, Maria Buti  Gastroenterology 
David H. Bruining, William J. Sandborn 
Volume 135, Issue 5, Pages e1 (November 2008)
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Venkata Rajesh Konjeti, Douglas Heuman, Jasmohan S
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Volume 149, Issue 6, Pages (November 2015)
Volume 150, Issue 7, Pages (June 2016)
Volume 136, Issue 7, Pages (June 2009)
Manuel Romero-Gómez, Javier Ampuero  Gastroenterology 
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis  Arun J. Sanyal, Pouneh S. Mofrad, Melissa.
Richard J. Saad, William D. Chey  Gastroenterology 
Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo  Barjesh Chander Sharma, Praveen.
Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial  Manish Kumar Lunia, Barjesh Chander Sharma, Praveen.
Richard Blumberg, Judy Cho, James Lewis, Gary Wu  Gastroenterology 
Volume 140, Issue 7, Pages (June 2011)
Jonathan T. Hlivko, Mitchell L. Shiffman, R. Todd Stravitz, Velimir A
Advances in Minimally Invasive Surgery
Changing of the Guards: 2011–2016 Gastroenterology Team
Yun-Fan Liaw, Wen-Juei Jeng, Ming-Ling Chang  Gastroenterology 
Volume 148, Issue 4, Pages (April 2015)
Volume 156, Issue 3, Pages (February 2019)
Volume 155, Issue 6, Pages (December 2018)
Jasmohan S. Bajaj, Kia Saeian, Muhammad Hafeezullah, Raymond G
Volume 139, Issue 6, Pages e1 (December 2010)
Capsule Endoscopy for Refractory Iron Deficiency Anemia in Crohn’s Disease: Captivating Pathology, Hybrid Therapy  Long Le, Brian M. Fung, James H. Tabibian 
Volume 152, Issue 5, Pages e1 (April 2017)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Reinvesting in US Biomedical Research—The Time is Now
Electronic Clinical Challenges and Images in GI
Controversies in Liver Transplantation for Hepatitis C
Volume 135, Issue 5, Pages e1 (November 2008)
A Female Patient With Persistent Epigastric Pain for 1 Week
Volume 156, Issue 4, Pages (March 2019)
Unrelenting Abdominal Pain after Recent Initiation of a Direct Oral Anticoagulant: A Cause for Concern  Nicholas R. Crews, Nabil Fayad  Gastroenterology 
Presentation transcript:

Volume 138, Issue 7, Pages 2332-2340 (June 2010) Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy  Jasmohan S. Bajaj, Christine M. Schubert, Douglas M. Heuman, James B. Wade, Douglas P. Gibson, Allyne Topaz, Kia Saeian, Muhammad Hafeezullah, Debulon E. Bell, Richard K. Sterling, R. Todd Stravitz, Velimir Luketic, Melanie B. White, Arun J. Sanyal  Gastroenterology  Volume 138, Issue 7, Pages 2332-2340 (June 2010) DOI: 10.1053/j.gastro.2010.02.015 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Learning impairment in patients with cirrhosis and overt hepatic encephalopathy. The first half of the ICT is identical to the second half; therefore, learning capability and working memory can be tested using ICT performance. There was a significant learning effect in normal cirrhotic patients and those with minimal HE but not in overt HE. This indicates a learning impairment in overt HE despite adequate therapy in these patients. A high number of lures indicates poor psychometric performance on the ICT. 1st, Lures in the first half, 2nd, lures in the second half; overt HE, recent overt hepatic encephalopathy controlled on lactulose therapy. Gastroenterology 2010 138, 2332-2340DOI: (10.1053/j.gastro.2010.02.015) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Change in lure performance on the ICT in patients before and after the development of overt hepatic encephalopathy. (A) There was a significant improvement in lures before overt HE development. (B) After those patients developed overt HE, this learning effect on lures disappeared. Fourteen of 15 (93%) patients were able to learn the ICT before developing overt HE, whereas only 4 (26%) were able to reduce their lures once they developed overt HE (P = .0001). I–III lures, lures in the first half of the ICT; IV–VI lures, lures in the second half of the ICT; OHE, overt hepatic encephalopathy controlled on lactulose therapy. Gastroenterology 2010 138, 2332-2340DOI: (10.1053/j.gastro.2010.02.015) Copyright © 2010 AGA Institute Terms and Conditions